Case Report: Sarcoidosis in Patient with History of IgG4-Related Disease

Veronica Matto, DO, began a fellowship in rheumatology at Larkin Community Hospital, Miami, in July 2021.

Rajshri Shah, MD, is an associate pathologist with Comprehensive Pathology Associates PA and is affiliated with Baptist Hospital of Miami.

Jie Ouyang, MD, PhD, is a pathologist for AdventHealth Orlando, Florida, and member of the United States and Canadian Academy of Pathology.

Cory Perugino, DO, is a rheumatologist and physician-scientist at Massachusetts General Hospital, Boston, where he focuses on translational and basic immunology research pertinent to IgG4-related disease.

Joseph LaConti, MD, PhD, is a rheumatologist at the Center for Arthritis and Rheumatic Diseases, Miami, and member of the American Arthritis and Rheumatology Associates.

Disclosures

Dr. LaConti is a member of the AbbVie and GlaxoSmithKline speakers bureaus.

References

1. Thomas KW, Hunninghake GW. Sarcoidosis. JAMA. 2003 Jun 25;289(24):3300–3303.
2. Costabel U, Hunninghake GW. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J. 1999 Oct;14(4):735–737.
3. Khosroshahi A, Wallace ZS, Crowe JL, et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol. 2015 Jul;
   67(7):1688–1699.
4. Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Modern Pathology. 2012 Sep;25(9):1181–1192.
5. Wallace Z, Naden R, Chari S, et al. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Arthritis Rheumatol. 2020 Jan;72(1):7–19.
6. Michel L, Clairand R, Néel A, et al. Association of IgG4-related disease and sarcoidosis. Thorax. 2011 Oct;66(10):920–921.
7. Fogt F, Wellmann A, Lee V. Immunoglobulin G4-related disease (IgG4-RD) with associated sarcoidosis. J Ocular Biol. 2013;1(1):3.
8. Iannuzzi, MC, Rybicki, BA, Teirstein, AS. Sarcoidosis. N Engl J Med. 2007 Nov 22;357(21):2153–2165.
9. Khosroshahi A, Stone JH. Treatment approaches to IgG4-related systemic disease. Curr Opin Rheumatol. 2011 Jan;23(1):67–71.
10. Karim F, Paridaens D, Westenberg LEH, et al. Infliximab for IgG4-related orbital disease. Ophthalmic Plast Reconstr Surg. 2017 May/Jun;33(3S Suppl 1):S162–S165.
11. Jalaj S, Dunbar K, Campbell A, Kazim M. Treatment of pediatric IgG4-related orbital disease with TNF-α anhibitor. Ophthalmic Plast Reconstr Surg. 2017 Jan/Feb;
    34(1):e10–e12.
12. Wessendorf TE, Bonella F, Costabel U. Diagnosis of sarcoidosis. Clin Rev Allergy Immunol. 2015 Aug;49(1):54–62.
13. Yamamoto H, Yasuo M, Ichiyama T, et al. Cytokine profiles in the BAL fluid of IgG4-related respiratory disease compared with sarcoidosis. ERJ Open Res. 2015 Oct 23;1(2):00009-2015.